Background The reported incidence, prevalence and outcomes of atrial fibrillation (AF) in
patients with end-stage renal disease (ESRD) are variable. The risks and benefits of warfarin …

… Author links open overlay panel Manish M. Sood MD a , Leigh Anne Shafer MD b , Julie Ho
MD b , Martina Reslerova MD b , Greg Martinka MD c , Sean Keenan MD d , Sandra Dial MD …

Background Digital healthcare systems data could provide insights into the global prevalence
of chronic kidney disease (CKD). We designed the CaReMe CKD study to estimate the …

Potassium disorders are common in patients with kidney disease, particularly in patients with
tubular disorders and low glomerular filtration rate. A multidisciplinary group of researchers …

Objectives We performed a systematic review and meta-analysis to understand the role of
flow-mediated dilatation (FMD) of the brachial artery (BA) and peripheral arterial tonometry (…

The incidence and prevalence of heart failure (HF) and chronic kidney disease (CKD) are
increasing, and as such a better understanding of the interface between both conditions is …

… MSc 1 2 3 , Chris Koolage MSc 2 3 , Manish M. Sood MD 5 , Navdeep Tangri MD, PhD 1 2
3 … Support: Dr Sood receives funding from the Jindal Chair in Kidney Research. Dr Tangri is …

The global health burden of chronic kidney disease is rapidly rising, and chronic kidney
disease is an important risk factor for cerebrovascular disease. Proposed underlying …

Benefits and risks of antithrombotic agents remain unclear in the hemodialysis population.
To help clarify this we determined variation in antithrombotic agent use, rates of major …

… Our recommendation differs from the recommendation of the Kidney Disease Outcomes
Quality Initiative that “[w]hen patients reach stage 5 CKD [chronic kidney disease] (estimated …